| Serial Number | 79254181 |
| Word Mark | LUXCEPTAR |
| Filing Date | Tuesday, December 18, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 26, 2019 |
| Registration Number | 5917334 |
| Registration Date | Tuesday, November 26, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 10, 2019 |
| Goods and Services | Medical and veterinary preparations and articles for the immune modulation; pharmaceuticals and natural remedies namely, natural remedy preparations for the immune modulation; medicines for the immune modulation; pharmaceuticals for the immune modulation and for the prophylaxis of immune system related diseases and disorders; pharmaceutical preparations, namely, preparations for immune modulation and for prophylaxis of immune system related diseases and disorders; pharmaceutical drugs namely, preparations for immune modulation and for prophylaxis of immune system related diseases and disorders; pharmaceutical implants namely, implantable intravenously drug delivery devices sold filled with pharmaceutical preparations for the immune modulation; pharmaceutical preparations for activating cellular function; cellular function activating agents for medical purposes; clinical medical reagents; cultures of microorganisms for medical use; medical preparations namely, pharmaceuticals and biological compounds to support the growth of stem cells; surgical implants comprised of living tissues grown from stem cells; medical diagnostic reagents; stem cells for research purposes; stem cells for medical purposes; reagents for blood grouping for medical purposes; anti-cancer drugs namely pharmaceuticals for the treatment of cancer; compounds namely, anti-cancer preparations for treating cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer |
| Goods and Services | Human healthcare services; medical services; pharmaceutical consultancy services; medical diagnostic testing, monitoring, and reporting services; medical treatment services namely, medical diagnosis and treatment for the immune modulation and prophylaxis of immune system related diseases and disorders; surgical treatment services; medical services relating to the removal, treatment and processing of stem cells; analysis of human serum for medical treatment; analysis of human tissues for medical treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 17, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, March 17, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kiadis Pharma Netherlands B.V. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | NL |
| Party Name | Kiadis Pharma Intellectual Property B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | Kiadis Pharma Intellectual Property B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | Kiadis Pharma Intellectual Property B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Sunday, March 17, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 14, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, March 17, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, March 19, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 20, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 21, 2019 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 28, 2019 | REFUSAL PROCESSED BY MPU |
| Thursday, March 28, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 12, 2019 | REFUSAL PROCESSED BY IB |
| Friday, July 26, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 26, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 26, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 29, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 8, 2019 | ASSIGNED TO LIE |
| Wednesday, August 21, 2019 | NOTICE OF PUBLICATION |
| Tuesday, September 10, 2019 | PUBLISHED FOR OPPOSITION |
| Monday, March 16, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, November 26, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 26, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, March 16, 2020 | FINAL DISPOSITION PROCESSED |
| Friday, April 3, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, April 10, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 9, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Saturday, June 19, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |